when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,498 stories

Aug 19, 26STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and morestat

Aug 19, 26Moderna and Merck cancer vaccine returns ‘landmark’ result in melanomabiopharma dive

Aug 19, 26Merck and Sarah Cannon team up to boost oncology trial efficiencyfiercebiotech

Aug 19, 26Dissecting Chinese trial strategy in wake of deathsstat

Aug 19, 26Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in Chinaendpoints

Aug 19, 26Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, morebiospace

Aug 19, 26Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccineendpoints

Aug 19, 26STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trialstat

Aug 19, 26Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion proteinfiercebiotech

Aug 18, 26Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval pushfiercebiotech

Aug 18, 26STAT+: Real-world psilocybin data suggest need for close monitoringstat

Aug 18, 26STAT+: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024stat

Aug 18, 26AstraZeneca scores in lung cancer; Sandoz inks a China dealbiopharma dive

Aug 18, 26STAT+: Government workers feel the squeeze on health carestat

Aug 18, 26Merck and Sarah Cannon team up to boost oncology trial efficiencyfiercebiotech

Aug 18, 26Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilarsbiospace

Aug 18, 26STAT+: Prominent AI startup rolls out virtual cell model in race to speed up sciencestat

Aug 18, 26Regeneron ends eye disease study due to antibody's safety profilebiospace

Aug 18, 26Regeneron ends eye disease study due to antibody's safety profilebiospace

Aug 18, 26STAT+: Amylyx endocrine drug succeeds in pivotal studystat

Aug 18, 26STAT+: A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle massstat

Aug 18, 26How health care costs are undermining America’s public-sector employersstat

Aug 18, 26Craif raises $33M to boost work on its urine test for cancerfiercebiotech

Aug 18, 26Johnson & Johnson MedTech nabs Monarch Quest 3 update for lung cancer detectionfiercebiotech

Aug 18, 26Assessing shared failures with AI is key to cell and gene therapy’s evolutionbiospace

Aug 18, 26Stakeholders call for flexibility in guidance aimed at reducing animal testing for cancer drugsraps

Aug 17, 26STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisitionstat

Aug 17, 26STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promisestat

Aug 17, 26Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 winfiercebiotech

Aug 17, 26AstraZeneca scraps Phase 3 trial of new bispecific in lung cancerbiopharma dive

← prevpage 21 of 50next →